A detailed history of Ossiam transactions in Repligen Corp stock. As of the latest transaction made, Ossiam holds 4,688 shares of RGEN stock, worth $584,734. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,688
Previous 1,948 140.66%
Holding current value
$584,734
Previous $245,000 184.49%
% of portfolio
0.01%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $328,224 - $458,539
2,740 Added 140.66%
4,688 $697,000
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $9,240 - $14,087
77 Added 4.12%
1,948 $245,000
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $66,091 - $80,658
387 Added 26.08%
1,871 $344,000
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $8,326 - $10,590
60 Added 4.21%
1,484 $235,000
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $94,125 - $122,610
680 Added 91.4%
1,424 $201,000
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $32,240 - $41,402
209 Added 39.07%
744 $125,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $85,824 - $137,072
535 New
535 $100,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.